How do you intensify therapy in patients with MAC lung disease who have more advanced disease or disease that is demonstrated to be refractory to the initial three-drug regimen? What is the role of amikacin?

How do you intensify therapy in patients with MAC lung disease who have more advanced disease or disease that is demonstrated to be refractory to the initial three-drug regimen? What is the role of amikacin?

How do you intensify therapy in patients with MAC lung disease who have more advanced disease or disease that is demonstrated to be refractory to the initial three-drug regimen? What is the role of amikacin?


Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | NTM-Pulmonary Infection Intelligence Zone

Presenter

Patrick Flume, MD

Patrick Flume, MD

Professor of Medicine and Pediatrics
Medical University of South Carolina
Powers-Huggins Endowed Chair for Cystic Fibrosis
University of South Carolina
Charleston, South Carolina